聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 18 分钟 54 秒 前

Dynatronics Strengthens Its Sales Management Team

周四, 05/26/2016 - 13:41
COTTONWOOD HEIGHTS, Utah, May 26, 2016 -- (Healthcare Sales & Marketing Network) -- Dynatronics Corporation (DYNT), a manufacturer and distributor of advanced-technology medical devices and rehabilitation equipment for the physical therapy, sports medicin...
Devices, Orthopaedic, Personnel
Dynatronics, physical therapy, rehabilitation equipment

TransMedics, Inc. Announces Closing of $51.2 Million Growth Financing to Transform Organ Transplant Therapy

周四, 05/26/2016 - 13:36
ANDOVER, Mass., May 26, 2016 -- (Healthcare Sales & Marketing Network) -- TransMedics, Inc., a medical technology company dedicated to improving quality, assessing viability and increasing the utilization of donor organs for transplantation announces toda...
Devices, Venture Capital
TransMedics, Organ Care System

Valeant Pharmaceuticals Names Sam Eldessouky Senior Vice President And Corporate Controller

周四, 05/26/2016 - 13:29
LAVAL, Quebec, May 26, 2016 -- (Healthcare Sales & Marketing Network) -- Valeant Pharmaceuticals International, Inc. (VRX) (VRX) ("Valeant") today announced that Sam Eldessouky has been named Senior Vice President and Corporate Controller effect...
Biopharmaceuticals, Personnel
Valeant Pharmaceuticals International

Third Installation of Elekta’s High-Field MR-Guided Linear Accelerator Underway at University Medical Centre Utrecht

周四, 05/26/2016 - 13:23
Reinforces commitment to research exploring how real-time clinical imaging coupled with precision radiotherapy can improve patient outcomes STOCKHOLM--(Healthcare Sales & Marketing Network)--Elekta (EKTA-B.ST) and Royal Philips (NYSE:PHG, AEX:PHIA) toda...
Devices, Oncology
Elekta, Royal Philips, MR-guided linear accelerator, MR-linac

HeartStitch(R) Announces New Director of Regulatory Affairs and Quality Assurance

周三, 05/25/2016 - 17:19
Faye Dunn Brings Wide-Ranging Experience to HeartStitch(R) Management and Manufacturing FOUNTAIN VALLEY, CA--(Healthcare Sales & Marketing Network) - Following a detailed search among a field of highly qualified candidates, the HeartStitch® Board of...
Devices, Cardiology, Personnel
HeartStitch, NobleStitch, vascular suture, PFO

Cynosure Announces Planned Retirement of Timothy W. Baker as President, Chief Financial Officer and Chief Operating Officer

周三, 05/25/2016 - 17:07
WESTFORD, Mass., May 25, 2016 -- (Healthcare Sales & Marketing Network) -- Cynosure, Inc. (CYNO) today announced that Timothy W. Baker has notified the Company that he plans to retire to pursue philanthropic interests. Mr. Baker has served as Cynosure's P...
Devices, Personnel
Cynosure, SculpSure

Ceterix Announces Appointment of Edward Graubart as Vice President, Sales

周三, 05/25/2016 - 13:56
Seasoned Executive Brings Wealth of Sales, Product Launch Experience MENLO PARK, Calif.--(Healthcare Sales & Marketing Network)--Ceterix® Orthopaedics, Inc., a developer of novel surgical tools that improve a surgeon’s ability to perform minimally i...
Devices, Orthopaedic, Personnel
Ceterix Orthopaedics, NovoStitch Plus, meniscal tear

Inivata Boosts Executive Team With Appointment of Clive Morris as Chief Medical Officer

周三, 05/25/2016 - 13:48
CAMBRIDGE, England, May 25, 2016 -- (Healthcare Sales & Marketing Network) -- Inivata, a global clinical cancer genomics company employing the precision of circulating tumour DNA (ctDNA) analysis to improve personalised healthcare in oncology, today annou...
Diagnostics, Personnel
Inivata Limited, ctDNA analysis, ctDNA, cancer genomics

Elekta Wins Public Tender to Deliver Advanced Cancer Care Solutions to New Karolinska Solna (NKS)

周三, 05/25/2016 - 13:43
STOCKHOLM--(Healthcare Sales & Marketing Network)--Stockholm County Council (Sweden), announced today that Elekta has been awarded the public tender to exclusively equip the Radiation Therapy Department of its new, flagship hospital, the New Karolinska Sol...
Devices, Oncology, Neurosurgery
Elekta, radiation therapy, radiosurgery, brachytherapy

Roche announces the first FDA-approved CMV test for use in hematopoietic stem cell transplant recipients

周三, 05/25/2016 - 13:35
New test standardizes CMV testing for both solid organ and hematopoietic stem cell transplant recipients PLEASANTON, Calif., May 25, 2016 -- (Healthcare Sales & Marketing Network) -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the United States ...
Diagnostics, FDA
Roche Group, cytomegalovirus

Cynosure Receives FDA Clearance to Market New PicoSure(R) Energy Delivery System for Tattoos and Pigmented Lesions

周二, 05/24/2016 - 15:13
Shipments of New 1064 nm Wavelength to Begin in the Second Half of 2016 WESTFORD, Mass., May 24, 2016 -- (Healthcare Sales & Marketing Network) -- Broadening its product platform for tattoo removal and skin revitalization, Cynosure, Inc. (CYNO) today a...
Devices, Dermatology, FDA
Cynosure, PicoSure, picosecond laser, tattoo

Amplyx Pharmaceuticals Appoints Paul C. Grint, M.D., to Board of Directors

周二, 05/24/2016 - 15:10
SAN DIEGO, May 24, 2016 -- (Healthcare Sales & Marketing Network) -- Amplyx Pharmaceuticals today announced the appointment of Paul C. Grint, M.D., to its Board of Directors. Dr. Grint, president and CEO, Regulus Therapeutics, joined Regulus in June 2014 ...
Biopharmaceuticals, Personnel
Amplyx Pharmaceuticals, Candida, Aspergillus

Allergan Announces FDA Acceptance of NDA Filing for Oxymetazoline HCI Cream 1.0%

周二, 05/24/2016 - 15:07
Potential Treatment for Patients with Facial Erythema (Redness) Associated with Rosacea Allergan Expects PDUFA Date in First Half 2017 DUBLIN, May 24, 2016 -- (Healthcare Sales & Marketing Network) -- Allergan plc (AGN) today announced that the New ...
Biopharmaceuticals, Dermatology, FDA
Allergan, Oxymetazoline, rosacea

Centinel Spine(TM) Expands STALIF(R) Internationally

周二, 05/24/2016 - 13:01
NEW YORK, May 24, 2016 -- (Healthcare Sales & Marketing Network) -- Centinel Spine, Inc., (Centinel Spine), the pioneer of Stand-Alone, No-Profile®, Integrated Interbody™ fusion devices, expands its MIDLINE II-Ti product family, a Ti-ACTIVE™ coated, N...
Devices, Orthopaedic, Neurosurgery
Centinel Spine, Interbody fusion device, MIDLINE II-Ti, spine surgery

Interventional Spine, Inc. announces FDA Clearance of Lordotic Opticage(TM)

周二, 05/24/2016 - 12:52
IRVINE, Calif., May 24, 2016 -- (Healthcare Sales & Marketing Network) -- Interventional Spine, Inc. announced today FDA clearance of its 80 Lumbar Lordotic Opticage™ Expandable Intervertebral Body Fusion Device. This device joins the Interventional Spine...
Devices, Orthopaedic, Neurosurgery, FDA
Interventional Spine, Lordotic Opticage, Interbody Fusion Devices, spine surgery

NuVasive Launches Next Generation Biologics Technology

周一, 05/23/2016 - 18:51
FDA Cleared Synthetic Bone Graft With Novel Surface Structure That Promotes Bone Formation SAN DIEGO, CA--(Healthcare Sales & Marketing Network) - NuVasive, Inc. (NUVA), a leading medical device company focused on transforming spine surgery with minimal...
Devices, Orthopaedic, Neurosurgery, Product Launch
NuVasive, AttraX Putty, synthetic bone graft, spine surgery

Interpace Diagnostics Presents New Clinical Utility Data at Digestive Disease Week

周一, 05/23/2016 - 14:03
Dr. James Farrell of Yale University Presents Key Findings from Analysis of 13,000 Patient Database SAN DIEGO, May 23, 2016 -- (Healthcare Sales & Marketing Network) -- Interpace Diagnostics Corp. (IDXG), a company that provides clinically useful molec...
Diagnostic, Gastroenterology, Oncology
Interpace Diagnostics, PancraGEN, pancreatic cancer

Egalet Settles Patent Litigations with Purdue Pharma

周一, 05/23/2016 - 13:56
No financial obligations to either party WAYNE, Pa., May 23, 2016 -- (Healthcare Sales & Marketing Network) -- Egalet Corporation (EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and ...
Biopharmaceuticals, Litigation
Egalet Corporation, Purdue Pharma, OXAYDO

OncoSec Announces $10 Million At-The-Market Registered Direct Offering

周一, 05/23/2016 - 13:50
SAN DIEGO, May 23, 2016 -- (Healthcare Sales & Marketing Network) -- OncoSec Medical Incorporated ("OncoSec") (ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that it has entered into a definitive agree...
Biopharmaceuticals, Oncology, Venture Capital
OncoSec Medical, ImmunoPulse

Zambon Launches Xadago(R) (Safinamide) in the U.K. for Patients with Mid- to Late-Stage Parkinson’s Disease

周一, 05/23/2016 - 13:42
Zambon today announces the availability in the U.K. of Xadago® (safinamide) for the treatment of adult patients with idiopathic Parkinson’s disease (PD) as an add-on therapy to a stable dose of Levodopa (L-dopa) alone or in combination with other Parki...
Biopharmaceuticals, Neurology, Product Launch
Newron Pharmaceuticals, Zambon, Xadago, Parkinson’s disease

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong